Urokinase is a negative modulator of Egf-dependent proliferation and motility in the two breast cancer cell lines MCF-7 and MDA-MB-231.
about
HER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast cancerHypoxia-inducible factor prolyl hydroxylase 2 (PHD2) is a direct regulator of epidermal growth factor receptor (EGFR) signaling in breast cancer.Serine peptidase inhibitor Kazal type I (SPINK1) promotes BRL-3A cell proliferation via p38, ERK, and JNK pathways.Lapatinib Inhibits Breast Cancer Cell Proliferation by Influencing PKM2 Expression.Epsilon-aminocaproic acid prevents high glucose and insulin induced-invasiveness in MDA-MB-231 breast cancer cells, modulating the plasminogen activator system.
P2860
Urokinase is a negative modulator of Egf-dependent proliferation and motility in the two breast cancer cell lines MCF-7 and MDA-MB-231.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Urokinase is a negative modula ...... ll lines MCF-7 and MDA-MB-231.
@en
type
label
Urokinase is a negative modula ...... ll lines MCF-7 and MDA-MB-231.
@en
prefLabel
Urokinase is a negative modula ...... ll lines MCF-7 and MDA-MB-231.
@en
P2860
P356
P1476
Urokinase is a negative modula ...... ll lines MCF-7 and MDA-MB-231.
@en
P2093
Lyudmyla Drobot
Nina Kozlova
P2860
P304
P356
10.1002/MC.22267
P577
2015-01-15T00:00:00Z